United States News All stories

Xanadu (NASDAQ:XNDU) and Lockheed Martin (NYSE:LMT) announced a strategic collaboration to expand internal quantum programming training.

Summit Therapeutics (NASDAQ:SMMT) sold its investigational Phase III precision antibiotic ridinilazole to Biossil for up to $105 million.

Fastenal (NASDAQ:FAST) reported second-quarter revenue of $2.39 billion and earnings per share of $0.33.

Bank of America (NYSE:BAC) reported second-quarter earnings per share of $1.21 on $31.6 billion in total revenue.

JPMorgan Chase (NYSE:JPM) reported a second-quarter earnings per share of $7.70 on $57.35 billion in total revenue.

Wells Fargo (NYSE:WFC) reported a 17% increase in net income to $6.41 billion for the second quarter.

Spero Therapeutics (NASDAQ:SPRO) licensed SP001 from Innovent Biologics in an agreement valued at approximately US$1.1 billion.

NextCure (NASDAQ:NXTC) agreed to merge with privately held Avere Therapeutics in an all-stock transaction supported by a concurrent $320 million private placement.

Beam Global (NASDAQ:BEEM) reported preliminary Q2 2026 revenue above $8.5 million, up more than 170% sequentially and over 20% annually.

AngioDynamics (NASDAQ:ANGO) reported fiscal fourth-quarter revenue of $86.6 million, up 8%, as Med Tech growth offset a wider $11.4 million GAAP net loss.

Unity Bancorp (NASDAQ:UNTY) reported second-quarter net income of $14.5 million, or $1.42 per diluted share, compared with US$14.3 million and US$1.40 in the previous quarter.

SemiLEDs (NASDAQ:LEDS) reported fiscal Q3 2026 revenue of $9.1 million and net income of $1.5 million, reversing the previous quarter’s loss.

Nayax (NASDAQ:NYAX) completed technical remediation and cleared its systems of unauthorized access following a July 2026 security incident.

Google parent Alphabet (NASDAQ:GOOGL) faces a Swiss preliminary investigation after Google removed Android’s Choice Screen in a market where it holds an estimated 82% search share.

BP (NYSE:BP) expects stronger oil realizations to add US$1.8 billion–US$2.1 billion to second-quarter upstream earnings despite production falling to 2.17 million–2.22 million boe/d.

Brent crude rose US$2.74, or 3.29%, to US$86.04, while West Texas Intermediate crude gained US$2.21, or 2.83%, to US$80.35 as renewed U.S.-Iran attacks threatened Strait of Hormuz energy flows.

Mesoblast (NASDAQ:MESO) treated at least 300 patients in MSB-DR004, reaching the pivotal Phase 3 treatment target for rexlemestrocel-L in chronic low back pain.

SILITH Technology and United Microelectronics (NYSE:UMC) delivered the first mass-produced photonic integrated circuit wafers from UMC’s Singapore fab for SILITH’s 1.6T silicon photonics platform.

VEON (NASDAQ:VEON) completed its acquisition of 76.33% of TPL Insurance for approximately PKR 4.55 billion, or US$16.4 million.

WISeKey (NASDAQ:WKEY) reported preliminary H1 2026 revenue of approximately US$11.4 million, up 115%, while its cash and short-term investments reached about US$495 million with zero debt.

Grupo Aeroportuario del Pacifico (NYSE:PAC) reported 2Q26 revenue of Ps. 11,289.7 million, up 3.7%, as EBITDA rose 8.4% and net income increased 9.0% following the CBX combination.

ProMIS Neurosciences (NASDAQ:PMN) reported first human evidence that PMN310 reduced detectable amyloid-beta oligomers in cerebrospinal fluid dose-dependently at days three and 29, providing an exploratory signal that the antibody reached and engaged its intended target.

Twelve US states have filed a lawsuit in an Oakland federal court to block Paramount's proposed US$110 billion acquisition of Warner Bros Discovery (NASDAQ:WBD).

The United States government reimposed a naval blockade on Iranian commerce through the Strait of Hormuz and announced a 20% toll.